Disease Info Card

Infiltrating Cervical Carcinoma

Information about Infiltrating Cervical Carcinoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Infiltrating Cervical Carcinoma

Most recent studies have shown that Infiltrating Cervical Carcinoma shares some biological mechanisms with adenocarcinoma, carcinoma, carcinoma-in-situ, cervical-dysplasia, cervical-intraepithelial-neoplasia, dysplasia, hiv-infections, infective-disorder, intraepithelial-neoplasia, intrahepatic-cholangiocarcinoma, invasive-malignant-neoplasm, malignant-neoplasms, malignant-squamous-cell-neoplasm, malignant-tumor-of-cervix, neoplasm-invasiveness, neoplasm-metastasis, neoplasms, papillomavirus-infections, tumor-virus-infections, uterine-cervical-neoplasm.

Among the many pathways, these few ones have gauged particular interests from scientists studying Infiltrating Cervical Carcinoma, and have been seen in publications frequently: Angiogenesis, Cell Cycle, Cell Death, Cell Growth, Cell Proliferation, Coagulation, Dna Amplification, Dna Methylation, Immune Response, Localization, Menarche, Menopause, Menstruation, Methylation, Oncogenesis, Ovulation, Pathogenesis, Reproductive Behavior, Transport, Transposition

Quite a number of genes have been found to play important roles in Infiltrating Cervical Carcinoma, such as ASAP1, ASAP2, CD4, CDKN2A, CISH, DBT, FAM49B, MRPS30, NDUFB6, PAPOLA, PDAP1, PDXP, PMEL, REG3A, SERPINB3, TP53, TUSC2, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.